The Following Appears on asia.nikkei.com Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025 TOKYO — Ricoh will acquire U.S.-based biotechnology startup Elixirgen Scientific as early as July in a push to turn messenger RNA technology into a core business, Nikkei has learned. Click Here to Read the Rest SOURCE Nikkei Ricoh … Continue reading Ricoh Jumps into mRNA Pharmaceuticals with U.S. Startup Deal